Rosenau Family Research Foundation
Historical FunderWaseca, Minnesota · EIN 26-3070514 · Private foundation · Website
Half of its grants to organizations were between $60,000 and $125,000.
How to apply
The foundation filed the following application information (Form 990-PF Part XV, tax year 2024):
| Contact | Paul Rosenau |
|---|---|
| Address | 104 10th Avenue SE, Waseca MN 56093 |
| Phone | 5078338144 |
| info@dufaultcpa.com | |
| Form and materials | Letter Outlining Project - Including Financial Data |
| Deadlines | None |
| Restrictions | Childhood Diseases and Newborn Screening for Disease - Particularly Krabbe's and Cystic Fibrosis |
Copied as filed. Deadlines on a tax return describe the foundation's usual process; they are not confirmation of a current open cycle.
What it funds
Share of grant lines on the latest return, classified from the purpose each grant states.
Where it gives
85% of grants went outside Minnesota.
Grants paid in tax year 2024
| Recipient | Location | Purpose | Amount |
|---|---|---|---|
| Duke University | Durham, NC | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | $250,000 |
| University of Connecticut Health Ce | Farmington, CT | Evaluation of Immunomodulatory Therapy for the Treatment of KD | $175,049 |
| Biomedical Research Institute of NJ | Cedar Knools, NJ | Psychosine Profiling and Evaluation as a Therapeutic for KD | $149,154 |
| University of Illinois | Chicago, IL | A Maladaptive Pathway Involved In Early Pathogenesis of KD | $125,000 |
| University of Buffalo | Amherst, NY | Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD | $125,000 |
| Nationwide Children's Hospital | Columbus, OH | Evaluation of In Utero Gene Therapy in Canine KD | $125,000 |
| University of Pittsburgh | Pittsburgh, PA | Disclosure of Newborn Screening Results for KD in Pennsylvania | $125,000 |
| University of Minnesota | Minneapolis, MN | GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD | $125,000 |
| University of Illinois | Chicago, IL | Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function | $85,000 |
| University of Pennsylvania | Philadelphia, PA | Elucidating the Mechanisms Underlying Macrophage Dysfunction in KD | $60,000 |
| University of Illinois | Chicago, IL | Dysfunction of Brain Synapsis in KD | $60,000 |
| University of Illinois | Chicago, IL | Effects of Motor Learning on Efficacy and Safety of AAV-Gene Therapy in KD | $60,000 |
| University of Kansas | Kansas City, KS | Improving Developmental Outcomes in Mouse Models of KD | $59,593 |
| Mayo Clinic | Rochester, MN | Elucidating the Metabolic Signature of KD Plasma, Dried Blood Spots, and Cerebrospinal Fluid Using Flux Analysis | $57,359 |
The return also lists 1 grant to individuals ($123,982). We do not publish the names of individual recipients.
Grants approved for future payment
| Recipient | Location | Purpose | Amount |
|---|---|---|---|
| Nationwide Children's Hospital | Columbus, OH | Evaluation of In Utero Gene Therapy in Canine KD | $250,000 |
| University of Pittsburgh | Pittsburgh, PA | Disclosure of Newborn Screening Results for KD in Pennsylvania | $250,000 |
| UW Department of Pediatrics | Madison, WI | Enriching CF Newborn Screening Outcomes Through a Precision Personalized Medicine Strategy | $250,000 |
| University of Minnesota | Minneapolis, MN | GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD | $235,000 |
| Duke University | Durham, NC | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | $125,000 |
| University of Illinois | Chicago, IL | A Maladaptive Pathway Involved In Early Pathogenesis of KD | $125,000 |
| University of Buffalo | Amherst, NY | Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD | $125,000 |
| University of Illinois | Chicago, IL | Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function | $85,000 |
| Mayo Clinic | Rochester, MN | Elucidating the Metabolic Signature of KD Plasma, Dried Blood Spots, and Cerebrospinal Fluid Using Flux Analysis | $55,359 |
Giving by year
| Tax year | Grants paid | Grant lines |
|---|---|---|
| 2024 | $1,705,137 | 24 |
| 2023 | $1,266,475 | 20 |
Sources
- IRS Form 990-PF, tax year 2024, filed Oct 7, 2025 - IRS e-file batch, object ID 202502809349101005
- IRS Tax Exempt Organization Search for EIN 26-3070514
- Profile updated Nov 6, 2026
Facts on this page come from the foundation's own IRS Form 990-PF filings as published by the IRS. Grantvello does not know whether a foundation is accepting proposals right now: a past grant is not an open opportunity. Always confirm current guidelines with the funder before applying.